High-Dose Levofloxacin in Community-Acquired Pneumonia: A Randomized, Open-Label Study

Author： > > > > >

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.32, Iss.9, 2012-09, pp. : 569-576

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nemonoxacin met the primary endpoint of noninferiority versus levofloxacin for community-acquired pneumonia

Inpharma, Vol. 1, Iss. 1634, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Tigecycline: In Community-Acquired Pneumonia

By McKeage Kate Keating Gillian M.

Drugs, Vol. 68, Iss. 18, 2008-01 ,pp. : 2633-2644

Adis International

Access to resources Recommend Favorite

Community‐Acquired Pneumonia

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 3, 2004-09 ,pp. : 212-217

John Wiley & Sons Inc

Access to resources Recommend Favorite

Formulation Selection and Pharmacokinetic Comparison of Fentanyl Buccal Soluble Film with Oral Transmucosal Fentanyl Citrate: A Randomized, Open-Label, Single-Dose, Crossover Study

By Vasisht Niraj

Clinical Drug Investigation, Vol. 29, Iss. 10, 2009-10 ,pp. : 647-654

Adis International

Access to resources Recommend Favorite

Bioequivalence of Sitagliptin/Metformin Fixed-Dose Combination Tablets and Concomitant Administration of Sitagliptin and Metformin in Healthy Adult Subjects: A Randomized, Open-Label, Crossover Study

By Migoya Elizabeth M.

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 855-866

Adis International

Access to resources Recommend Favorite